/ANNX.ST
ANNX.ST Stock - Annexin Pharmaceuticals AB (publ)
Healthcare|BiotechnologySTO
$19.00-5.94%
$1.20 (-5.94%) • Dec 23
56
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.4
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $20.90
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ANNX.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$18.81 – $19.19
TARGET (TP)$21.85
STOP LOSS$17.48
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.24
52W High$54.09
52W Low$17.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-193,000 | $-193,000 | $-193,000 | $-192,000 | $-193,000 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-50,480,000 | $-44,176,000 | $-40,724,000 | $-51,233,000 | $-43,737,000 |
| Net Income | $-50,252,000 | $-44,054,000 | $-40,726,000 | $-52,142,000 | $-44,240,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.11 | $-0.26 | $-0.17 | $-0.39 | $-0.39 |
Company Overview
Annexin Pharmaceuticals AB (publ), a biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases. The company develops ANXV, a human recombinant protein. It offers Annexin A5 to protect and repair blood vessels and counteract inflammation. The company was founded in 2014 and is based in Stockholm, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ANNX.STBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-1.38
Q2 2025
EPS Surprise History
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q2 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | Jun 30, 2025 | — | $-1.38 | — | — |
Q2 2025 | May 14, 2025 | — | $-0.01 | — | — |
Q1 2025 | Feb 6, 2025 | — | $-0.03 | — | — |
Q4 2024 | Oct 17, 2024 | — | $-0.02 | — | — |
Q3 2024 | Jul 18, 2024 | — | $-0.04 | — | — |
Q2 2024 | Apr 12, 2024 | — | $-0.04 | — | — |
Q1 2024 | Feb 9, 2024 | — | $-0.04 | — | — |
Q4 2023 | Oct 18, 2023 | — | $-0.04 | — | — |
Q3 2023 | Aug 3, 2023 | — | $-0.03 | — | — |
Q2 2023 | May 17, 2023 | — | $-0.06 | — | — |
Q1 2023 | Feb 7, 2023 | — | $-0.04 | — | — |
Q4 2022 | Nov 3, 2022 | — | $-0.06 | — | — |
Q3 2022 | Aug 23, 2022 | — | $-0.08 | — | — |
Q2 2022 | May 30, 2022 | — | $-0.07 | — | — |
Q1 2022 | Feb 3, 2022 | — | $-0.12 | — | — |
Q4 2021 | Nov 30, 2021 | — | $-0.10 | — | — |
Q3 2021 | Aug 19, 2021 | — | $-0.12 | — | — |
Q2 2021 | May 6, 2021 | — | $-0.15 | — | — |
Q1 2021 | Feb 4, 2021 | — | $-0.21 | — | — |
Q4 2020 | Oct 29, 2020 | — | $-0.06 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ANNX.ST
What is ANNX.ST's current stock price?
Annexin Pharmaceuticals AB (publ) (ANNX.ST) is currently trading at $19.00 per share. The stock has moved -5.94% today.
What is the analyst price target for ANNX.ST?
No analyst price targets are currently available for this stock.
What sector is Annexin Pharmaceuticals AB (publ) in?
Annexin Pharmaceuticals AB (publ) operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the STO exchange.
What is ANNX.ST's market cap?
Annexin Pharmaceuticals AB (publ) has a market capitalization of $0.13 billion, making it a small-cap company.
Does ANNX.ST pay dividends?
No, Annexin Pharmaceuticals AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorALZ.ST
Alzinova AB (publ)
$0.82
Mkt Cap: $0.1B
BIOWKS.ST
Bio-Works Technologies AB (publ)
$2.25
Mkt Cap: $0.2B
CLS-B.ST
Clinical Laserthermia Systems AB (publ)
$7.00
Mkt Cap: $0.2B
ERMA.ST
Enorama Pharma AB (publ)
$2.30
Mkt Cap: $0.2B
INIT.ST
Initiator Pharma A/S
$2.93
Mkt Cap: $0.2B
INTEG-B.ST
Integrum AB (publ)
$10.06
Mkt Cap: $0.2B
IRLAB-A.ST
IRLAB Therapeutics AB (publ)
$1.97
Mkt Cap: $0.2B
ISOFOL.ST
Isofol Medical AB (publ)
$0.72
Mkt Cap: $0.2B
KDEV.ST
Karolinska Development AB (publ)
$0.43
Mkt Cap: $0.1B
LIPUM.ST
Lipum AB (publ)
$14.55
Mkt Cap: $0.3B
Explore stocks similar to ANNX.ST for comparison